News
Filters
Showing 1 - 10 out of 39 results
News
KSHB: Henli the Facility Dog Making Positive Impact for Rehab Patients
Saint Luke's Rehabilitation Institute's newest staff member is making an immediate impact on patient care this year. Henli is a two-year old facility dog, highly trained to work in clinical settings alongside licensed therapists.
Article
KCTV: Saint Luke’s Patient Avoids Third Open Heart Surgery Thanks to Minimally Invasive Procedure
Born with congenital heart disease, 41-year-old Christin Murphy has undergone three heart surgeries to repair pulmonary valves. They have been tough to get through, but Murphy says this latest one at Saint Luke’s changed her outlook.
Article
Thera-Pup: Meet Henli the Facility Dog
Two years after an intern presented on the clinical and emotional benefits of service animals, the Rehabilitation Institute is delighted to introduce the world to Henli, a highly trained dog with a knack for comfort and connection.
Patient Stories
"Grateful and Humbled": The Back-to-Back Transplants at Saint Luke's that Saved One Man's Life
Anthony Weatherspoon, 68, of Lee’s Summit, Missouri, remembers it like it was yesterday: The day he wasn’t feeling very well in 2024. “I didn’t know what was up,” Anthony says, with his wife, Peggy, at his side.
Article
Dr. Cecilia Mathis has a Heart for Women’s Health
As a family medicine physician, Dr. Mathis specializes in providing quality care for men, women, and children of all ages.
News
BBC News: Studies Reveal New Effects of Semaglutide
BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.
Article
American Journal of Managed Care: Semaglutide Enhances Heart Failure Outcomes in Obesity
A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.
News
Healio: Treatment Effect of Bystander CPR Varies by Race, Sex
On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.
News
Cardiovascular Business: Semaglutide Improves Heart Failure Symptoms in Both Sexes—Weight Loss Greater in Women
Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.
Article
U.S. News & World Report: Mummies Study Finds Heart Disease Plagued the Ancients, Too
U.S. News & World Report shares results of a new study finding heart disease has plagued humanity for centuries.